Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CERS
DRUG
Add up to 3 more stocks
CERS
Cerus Corporation
+0.64%
$2.35+0.02Delayed quote: Oct 6, 2026, 2:14 PM EDT
Market Cap
$474.59M
52W Range
$1.38 - $3.47
DRUG
Bright Minds Biosciences Inc.
-2.28%
$48.66-1.13Delayed quote: Oct 6, 2026, 2:14 PM EDT
Market Cap
$476.19M
52W Range
$48.53 - $123.75
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 6.78 | 2.19 |
| P/S Ratio | 2.14 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | 8081.97 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 52.0% | 0.0% |
| Operating Margin | -0.7% | 0.0% |
| Net Margin | -3.1% | 0.0% |
| ROE | -9.7% | -8.2% |
| ROA | -3.3% | -8.1% |
| ROIC | -1.1% | -13.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.83 | 121.97 |
| Quick Ratio | 1.07 | 121.97 |
| Debt/Equity | 1.10 | 0.00 |
| Interest Coverage | -1.04 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.